Abstract

The article contains sections titled:

1 Introduction
1.1 All Other Therapeutic Products – Antidotes and Detoxifying Agents (V03)
1.2 Contrast Media (V08)
2 V03/V03A All Other Therapeutic Products
2.1 V03AB Antidotes
2.2 V03AC Iron-chelating Agents
2.3 V03AE Drugs for the Treatment of Hyperkalemia and -Phosphatemia
2.4 V03AF Detoxifying Agents for Antineoplastic Treatment
2.5 V03AG Drugs for Treatment of Hypercalcemia
2.6 V03AH Drugs for Treatment of Hyperglycemia
2.7 V03AX Other Therapeutic Products
3 V08 Contrast Media
3.1 V08A X-Ray Contrast Media, Iodinated
3.1.1 V08AA Water Soluble, Nephrotropic, and High-Osmolar X-Ray Contrast Media
3.1.2 V08AB Water Soluble, Nephrotropic, and Low-Osmolar X-Ray Contrast Media
3.1.3 V08AC Water Soluble, Hepatotropic X-Ray Contrast Media
3.1.4 V08AD Non-Water Soluble X-Ray Contrast Media
3.2 V08B X-Ray Contrast Media, noniodinated
3.2.1 V08BA Barium Sulfate Containing X-Ray Contrast Media
3.3 V08C Magnetic Resonance Imaging Contrast Media
3.3.1 V08CA Paramagnetic Contrast Media
3.3.2 V08CB Superparamagnetic Contrast Media
3.3.3 V08CX Other Magnetic Resonance Imaging Contrast Media
3.4 V08D Ultrasound Contrast Media
3.4.1 V08DA Ultrasound Contrast Media
List of Abbreviations
References

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.